Concourse Financial Group Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Concourse Financial Group Securities’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-163	Closed	-$12.4K	–	2426
2023 Q1	$12.4K	Sell	163 -214	-57%	-$16.5K	﹤0.01%	1604
2022 Q4	$29.6K	Buy	+377	New	+$29K	﹤0.01%	1298
2021 Q1	–	Sell	-117	Closed	-$9.13K	–	2394
2020 Q4	$8K	Sell	117 -42	-26%	-$2.81K	﹤0.01%	1756
2020 Q3	$10K	Sell	159 -152	-49%	-$9.93K	﹤0.01%	1588
2020 Q2	$20K	Sell	311 -790	-72%	-$49.1K	﹤0.01%	1301
2020 Q1	$61K	Sell	1,101 -70	-6%	-$4.26K	0.01%	825
2019 Q4	$76K	Buy	1,171 +1,123	+2,340%	+$68.3K	0.01%	798
2019 Q3	$3K	Sell	48 -1,193	-96%	-$68.6K	﹤0.01%	1462
2019 Q2	$75K	Buy	1,241 +1,098	+768%	+$67.4K	0.01%	737
2019 Q1	$9K	Hold	143	–	–	﹤0.01%	1551
2018 Q4	$8K	Buy	+143	New	+$9.65K	﹤0.01%	1499

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

PWW

Pettyjohn Wood & White Lynchburg, Virginia $687M AUM 24.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Concourse Financial Group Securities's PJP Position: Q2 2023 in Review

Concourse Financial Group Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2023, closing a stake of 163 shares — an estimated $12.4K sold.

Concourse Financial Group Securities first reported a position in PJP in Q4 2018 and held it in 11 quarters. The position peaked at $76K in Q4 2019. 87 funds tracked by Wall St. Rank hold PJP as of Q2 2023.

Concourse Financial Group Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 163 Invesco Pharmaceuticals ETF shares in Q2 2023, an estimated $12.4K.
Concourse Financial Group Securities first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 11 quarters.
Concourse Financial Group Securities's Invesco Pharmaceuticals ETF position peaked at $76K in Q4 2019.
87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2023.

Based on Concourse Financial Group Securities's 13F filing for Q2 2023, filed 10 Aug 2023.